A. James (Jim) Moser, MD, FACS, has joined the
Division of Surgical Oncology in the
Roberta and Stephen R. Weiner Department of Surgery as Executive Director of the new Institute for Hepatobiliary and Pancreatic Surgery at Beth Israel Deaconess Medical Center.
Moser comes to BIDMC from the University of Pittsburgh Medical Center (UPMC), where he was a staff surgeon in the Division of Surgical Oncology and Co-Director of the multidisciplinary UPMC Pancreatic Cancer Center. He was also Associate Professor of Surgery and Associate Professor of Cell Biology and Physiology at the University of Pittsburgh School of Medicine.
A graduate of Washington University School of Medicine in St. Louis, MO, Moser completed a residency in general surgery and a research fellowship in membrane biology at UCLA Center for Health Sciences and UCLA School of Medicine in Los Angeles, CA.
Moser serves as Executive Director of BIDMC's new Institute for Hepatobiliary and Pancreatic Surgery, providing leadership, strategic vision and integration of programs in general surgery, surgical oncology and transplant surgery that are focused on the surgical treatment of benign and malignant pancreatic, hepatic and biliary diseases. He has advanced surgical training and is a leader in complex, advanced robotic and minimally-invasive surgical oncology including pancreatic auto-islet transplantation.
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and currently
ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a research partner of Dana-Farber/Harvard Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information, visit